Conversational AI startup Simply Speak raises $1.1 million in seed
Simply Speak’s technology uses AI to help physicians document their interactions with patients through telemedicine tools
Simply Speak’s technology uses artificial intelligence to help physicians document their interactions with patients through telemedicine tools. The company, which has been bootstrapped since its establishment last year, saw a rise in demand following the coronavirus (Covid-19) outbreak, which forced more doctors to work remotely.
Simply Speak CEO Moti Tomashin. Photo: Cosilia Ramanarsh Simply Speak uses AI to extract meaningful medical data from conservations held between the patient and doctor. Using natural language processing tools, Simply Speak’s software integrates directly into existing electronic health record systems to improve notes taken by the doctor during the session.
- Israeli AI company partners with medical service to provide better cancer screening for NHS patients
- Sheba Medical Center names Intel winner of Covid-19 data challenge
- With FDA approval in hand and Covid-19 as a test case, Israel’s Clew is ready for its money time
“The big advantage that telehealth has over a regular phone call is the ability to maintain eye-contact with the patient,” Moti Tomashin, Simply Speak’s CEO and co-founder, said in a statement. Currently, however, he explained, physicians need to look away from the screen in order to take notes, losing the human aspect of the conversation.
Ultimately, Simply Speak intends to maintain the close relationship between physicians and those they serve even when treatment is given remotely. The conversational AI tool will assist in note-taking and ultimately save time on administrative tasks, helping doctors focus on their communication with patients during telemedicine appointments.
